Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

PDS Biotech Collaborating with Merck in Phase 2 Cancer Trial

This morning PDS Biotechnology Corp. shares are trading 38% higher after reporting that it will enter into a clinical collaboration with Merck pairing the firm's PDS0101 with KEYTRUDA for patients with recurrent or metastatic head and neck cancer and high-risk HPV16 infection....
Streetwise Reports | October 4, 2019 |

Smart City Security Takes Shape in Mexico City with Lighting and Analytics Collaboration

The two firms are bringing together lighting, cameras and analytic technology. Energetika, an international firm based in Mexico City that provides intelligent lighting solutions, is collaborating with VSBLTY Groupe Technologies Corp. (VSBY:CSE; VSBGF:OTC; 5VS:FRA) ,...
Streetwise Reports | November 21, 2019 |

NurExone Biologic announces important test results

By Brad Sorensen, CFA, Zacks Research. NurExone Biologic (TSXV:NRX; OTCQB:NRXBF) is developing a product known as ExoPTEN that is designed to treat patients with acute spinal cord injuries, while also conducting preclinical tests for other conditions that ExoPTEN m...
Research | December 11, 2024 |

Coverage Initiated on Cancer Vaccine Firm

An H.C. Wainwright & Co. report explained the reasons for its "bullish view" on this California-based life sciences company. In a March 7 research note, analyst Swayampakula Ramakanth reported that H.C. Wainwright & Co. initiated coverage on Gritstone Oncology Inc. (GR...
Streetwise Reports | March 11, 2019 |

Pulmatrix's Licensing Deal with the JNJ Lung Cancer Initiative Sends Shares Up 100%

Pulmatrix's shares opened 90% higher today after the firm reported that it has signed a kinase inhibitor licensing agreement with the Lung Cancer Initiative at Johnson & Johnson. Prior to the U.S. markets open this morning on the first day of trading in 2020, clinical...
Streetwise Reports | January 3, 2020 |

AIM ImmunoTech Shares Soar as Japan's NIID Tests Ampligen® as Potential Coronavirus Treatment

Shares of AIM ImmunoTech traded more than 150% higher after the company reported that Japan's National Institute of Infectious Diseases will test its Ampligen® drug as a potential treatment for the coronavirus. Immuno-pharmaceutical company AIM Imm...
Streetwise Reports | March 10, 2020 |

Curis' Shares Take Off as FDA Clears IND Application for Monoclonal Anti-VISTA Antibody

Curis Inc. shares are up more than 130% and established a new 52-week high price after reporting that the FDA cleared the company's IND Application for CI-8993, its monoclonal anti-VISTA antibody. Biotechnology company Curis Inc. (CRIS:NASDAQ) , which concentrates...
Streetwise Reports | June 11, 2020 |

Introducing: The Device to Replace Antiquated Paper-Based Systems

(Image via Visionstate Corp. Click to enlarge.) The Internet of Things (IoT) describes the network of physical objects “things” that are embedded with sensors, software, and other technologies for the purpose of connecting and exchanging data ...
Featured Submission | March 1, 2022 |

Buzz on the Bullboards: Old favourites make their return

September is often seen as a “fresh start” for the markets, like a new year on the stock exchange, but this party was met with a serious hangover in the shape of poor performances among sectors that only just recently began to turn around. One ma...
Jonathon Brown | September 14, 2023 |

Homerun Resources’ global reach and where it's headed

Focused on silica and working in the Bahia, Brazil, area with great interest is Homerun Resources (TSXV:HMR) . The company continues to focus its efforts on accessing massive amounts of high purity quartz to ensure a stable supply chain while meeting the increasing ...
Brieanna McCutcheon | December 6, 2023 |
1 2